1. An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes
    Ajda Ota et al, 2017, Front. Pharmacol. CrossRef
  2. Antioxidant and glucose metabolizing potential of edible insect, Brachytrupes orientalis via modulating Nrf2/AMPK/GLUT4 signaling pathway
    Prachurjya Dutta et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  3. Effectiveness of Antihyperglycemic Effect of Momordica charantia: Implication of T-Cell Cytokines
    Rufine Fachinan et al, 2017, Evidence-Based Complementary and Alternative Medicine CrossRef
  4. Molecular targets and mechanisms of bioactive peptides against metabolic syndromes
    Shanshan Li et al, 2017, Food Funct. CrossRef
  5. The Effect of Sanggua Drink Extract on Insulin Resistance through the PI3K/AKT Signaling Pathway
    Yu Cai et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
  6. Phytochemicals and their effective role in the treatment of diabetes mellitus: a short review
    Seong Lin Teoh et al, 2018, Phytochem Rev CrossRef
  7. Colocynthenins A–D, Ring-A seco-Cucurbitane Triterpenoids from the Fruits of Citrullus colocynthis
    Yushuang Liu et al, 2018, J. Nat. Prod. CrossRef
  8. Protective effect of triterpenes against diabetes-induced β-cell damage: An overview of in vitro and in vivo studies
    Sihle E. Mabhida et al, 2018, Pharmacological Research CrossRef
  9. Cucurbitane triterpenoids from the fruit of Momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities
    Jiayin Yue et al, 2019, Phytochemistry CrossRef
  10. Administration of Momordica charantia Enhances the Neuroprotection and Reduces the Side Effects of LiCl in the Treatment of Alzheimer’s Disease
    Hei-Jen Huang et al, 2018, Nutrients CrossRef
  11. null
    Merve Bacanli et al, 2019 CrossRef
  12. Selection and validation of appropriate reference genes for real-time quantitative PCR analysis in Momordica charantia
    Zhenglong Wang et al, 2019, Phytochemistry CrossRef
  13. Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery
    Ngan Tran et al, 2020, Biology CrossRef
  14. The triterpenoids of the bitter gourd (Momordica Charantia) and their pharmacological activities: a review
    Le Sun et al, 2020, Journal of Food Composition and Analysis CrossRef
  15. De Novo Assembly and Transcriptome Analysis of the Momordica charantia Seedlings Responding to Methyl Jasmonate Using 454 Pyrosequencing
    Shanyong Yi et al, 2020, Gene Expression Patterns CrossRef
  16. The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review
    Zhuo Liu et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  17. Exploring the inhibitory potentials of Momordica charantia bioactive compounds against Keap1-Kelch protein using computational approaches
    Temitope Isaac Adelusi et al, 2021, In Silico Pharmacol. CrossRef
  18. null
    Mohd Shuaib et al, 2021 CrossRef
  19. A Review on Phytopharmaceuticals having Concomitant Experimental Anti-diabetic and Anti-cancer Effects as Potential Sources for Targeted Therapies Against Insulin-mediated Breast Cancer Cell Invasion and Migration
    Vibhavana Singh et al, 2021, CCTR CrossRef
  20. A characterized saponin-rich fraction of Momordica charantia shows antidiabetic activity in C57BLK/6 mice fed a high fat diet
    Amy C. Keller et al, 2021, Phytomedicine Plus CrossRef
  21. Bitter Melon and Diabetes Mellitus
    Ya Gao et al, 2021, Food Reviews International CrossRef
  22. Flavonoids, alkaloids and terpenoids: a new hope for the treatment of diabetes mellitus
    Sukhpal Singh et al, 2022, J Diabetes Metab Disord CrossRef
  23. null
    Younis Ahmad Hajam et al, 2022 CrossRef
  24. Safety and Efficacy of Dietary Supplements for Diabetes
    Lourdes V. Cross et al, 2021 CrossRef
  25. Momordica charantia L.—Diabetes-Related Bioactivities, Quality Control, and Safety Considerations
    Serhat S. Çiçek, 2022, Front. Pharmacol. CrossRef
  26. Controlling diabetes with the aid of medicinal herbs: a critical compilation of a decade of research
    Shahida Anusha Siddiqui et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  27. New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review
    Awa Fanny Massounga Bora et al, 2023, International Journal of Biological Macromolecules CrossRef
  28. Naturally-occurring carboxylic acids from traditional antidiabetic plants as potential pancreatic islet FABP3 inhibitors. A molecular docking–aided study
    Ayman Hyder, 2023, Chemico-Biological Interactions CrossRef
  29. Anti-Glucotoxicity Effect of Phytoconstituents via Inhibiting MGO-AGEs Formation and Breaking MGO-AGEs
    Neera Yadav et al, 2023, IJMS CrossRef
  30. Antidiabetische Wirkung der Inhaltsstoffe von Momordica charantia
    Serhat S. Çiçek, 2023, Erfahrungsheilkunde CrossRef
  31. Identification and Analysis of Reference and Tissue-Specific Genes in Bitter Gourd Based on Transcriptome Data
    Yangyi Zheng et al, 2023, Horticulturae CrossRef
  32. Clinical application of Momordica charantia (Bitter Melon) for reducing blood sugar in type 2 diabetes mellitus
    Ashley Dahlquist et al, 2023, IJN CrossRef
  33. null
    Kilambi Pundarikakshudu et al, 2024 CrossRef